While many of us from the Daelight team have attended the Veeva R&D Summit in the past, 2019 was Daelight’s first year there as a partner and sponsor. Among 1,700 other life sciences leaders and experts, the event provided a valuable opportunity to connect with colleagues and customers and learn about the latest developments and trends in the space.
When not working our booth, members of our team were able to attend some breakout sessions. Our main takeaway? We were very impressed by Veeva’s ambitious development roadmap for the coming year.
Two areas in particular are creating unique value propositions for clinical trials and pharmacovigilance: The Align Clinical CRO project and Vault Safety.
The Align Clinical CRO Project
The Align Clinical CRO project was the hot topic for the sessions on Clinical Data Management and Clinical Operations.
The objective is for Clinical Research Organizations (CROs) to utilize the Veeva Vault Platform to enhance the way they provide study dataset reporting to study Sponsors. Using an industry standard as well as efficiencies gained in the Study Startup process, CROs will not have to negotiate these data elements. The data would then be socialized between the Sponsor, CRO and Sites directly through Vault. From this project, CROs will benefit from increased marketing exposure. Ultimately, this will shorten the timeline for studies and create a single source for operational data.
The current standard includes Phase II and III Trials as well as General Trial Information, Site Start Up, Patient Enrollment and Data Collection. Phase I and IV will be coming next in addition to other milestones. Interested CROs and Sponsors can participate in the standard’s development by clicking here.
Vault Safety
In the morning keynote session, Brian Longo, Veeva, general manager of safety, showed a demo of Vault Safety – Veeva’s new offering that aims to streamline adverse event management by assigning and routing cases for medical review.
Sponsors and CROs can leverage Vault Quality, Clinical, RIM and MedComms to author and review safety documentation in one single source system.
The most interesting part of this new offering to our team is the Vault Safety.AI technology. Safety.AI will use natural language processing to read center notes and other documents, converting it all to structured, reportable data. It can then use machine learning to take these data elements and detect duplicate adverse event reports.
Emerging technologies such as this will certainly create a new standard for process efficiency and reporting metric insights in the years to come.
Looking Forward: 2020 Veeva R&D Summit
Next year’s Veeva R&D Summit will be in Boston. We can’t wait to see how the Clinical ecosystem adopts Aligned CRO and Vault Safety – and what the roadmap will look like beyond 2020.
See you there!